0 items USD 0.00Search
Your search for "delveinsight chronic lymphocytic leukemia cll api insights 2017" gave back 17643 results.
Market Analysis and Insights: Global CAR-T Therapy Market The global CAR-T Therapy market is projected to grow from US$ million in 2023 to US$...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Acalabrutinib (ACP-196) is an orally active, irreversible, and highly selective second-generation BTK inhibitor. Acalabrutinib binds covalently to...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
The global Fludarabine Phosphate market size was valued at US$ million in 2023. With growing demand in downstream market, the Fludarabine Phosphate...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Acute lymphocytic/lymphoblastic leukemia (ALL) is a type of cancer that develops from immature lymphocytes. “Acute” here indicates leukemia that...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Acute Myeloid Leukemia Treatment market size was valued at US$ 578.8 million in 2023. With growing demand in downstream market, the Acute...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global CD20 Target Drug market size was valued at US$ million in 2022. With growing demand in downstream market, the CD20 Target Drug is forecast...
Catalog:
LPI
November 2023
Price: USD 3,660.00
